SCHEMBL32670341

SCHEMBL32670341

Fc1ccc(COc2cccc(CCl)c2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 9/20 0.64
MAOA P21397 2/20 0.59
KMT2A Q03164 3/20 0.58
MEN1 O00255 2/20 0.58
ALDH1A1 P00352 2/20 0.58
LMNA P02545 2/20 0.58
MAPT P10636 2/20 0.58
L3MBTL1 Q9Y468 2/20 0.58
THRB P10828 1/20 0.58
PKM P14618 1/20 0.58
RECQL P46063 1/20 0.58
RAB9A P51151 1/20 0.58
BLM P54132 1/20 0.58
CASP6 P55212 1/20 0.58
TDP1 Q9NUW8 1/20 0.58
NR4A2 P43354 1/20 0.57
SMN1; SMN2 Q16637 3/20 0.57
KDM4E B2RXH2 1/20 0.52
POLB P06746 1/20 0.50
TLR4 O00206 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30262573 0.86 BCHE (0.64) MAOBMAOAKMT2AMEN1ALDH1A1
SCHEMBL1680838 0.86 BCHE (0.64) MAOBMAOAKMT2AMEN1ALDH1A1
SCHEMBL2499037 0.86 MAOB (0.83) MAOBMAOAKMT2AMEN1ALDH1A1
SCHEMBL4158572 0.83 MAOB (0.69) MAOBMAOAKMT2AMEN1ALDH1A1
SCHEMBL5512565 0.83 MAOB (0.59) MAOBMAOANR4A2
SCHEMBL16710633 0.82 MAOB (0.71) MAOBMAOAKMT2AMEN1ALDH1A1
SCHEMBL4836597 0.80 MAOB (0.67) MAOBRAB9ANR4A2
SCHEMBL6417799 0.80 ALDH1A1 (0.65) MAOBMAOAKMT2AMEN1ALDH1A1
SCHEMBL22964303 0.79 APP (0.70) MAOBMAOAKMT2AMEN1ALDH1A1
SCHEMBL4412918 0.79 FDFT1 (0.46) KMT2AMEN1ALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035364-A1 BICYCLIC TETRAHYDROTHIAZEPINE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2026-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035364-A1 BICYCLIC TETRAHYDROTHIAZEPINE DERIVATIVES SCN1B, SCN2B, SCN11A MAOB 462/4885MAOA 803/4885KMT2A 1058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.